Detalles de la búsqueda
1.
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study.
Br J Haematol
; 197(1): 76-81, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34881427
2.
Expression of CD73 on leukemic blasts increases during follow-up - a promising candidate marker for minimal residual disease detection in pediatric B-cell precursor acute lymphoblastic leukemia.
Cent Eur J Immunol
; 47(1): 84-91, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35600149
3.
Multicolor flow cytometry immunophenotyping and characterization of aneuploidy in pediatric B-cell precursor acute lymphoblastic leukemia.
Cent Eur J Immunol
; 46(3): 365-374, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34764809
4.
The influence of fixation of biological samples on cell count and marker expression stability in flow cytometric analyses.
Cent Eur J Immunol
; 45(2): 206-213, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33456333
5.
Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction.
Genes (Basel)
; 13(8)2022 07 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36011285
6.
Machine Learning Based Analysis of Relations between Antigen Expression and Genetic Aberrations in Childhood B-Cell Precursor Acute Lymphoblastic Leukaemia.
J Clin Med
; 11(9)2022 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35566407
7.
Impact of Pre-Analytical and Analytical Variables Associated with Sample Preparation on Flow Cytometric Stainings Obtained with EuroFlow Panels.
Cancers (Basel)
; 14(3)2022 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158741
Resultados
1 -
7
de 7
1
Próxima >
>>